Search results
Author(s):
Fizzah A Choudry
,
Roshan P Weerackody
,
Daniel A Jones
,
et al
Added:
3 years ago
Over the last few decades, primary percutaneous coronary intervention (PCI) has revolutionised the treatment of ST-elevation myocardial infarction (STEMI) with rapid recanalisation of the infarct-related epicardial vessel, resulting in smaller infarct size and a substantial reduction in adverse clinical endpoints.1,2 However, suboptimal myocardial reperfusion is documented to occur in a…
View more
Author(s):
Dean J Kereiakes
Added:
4 years ago
Prof Dean J Kereiakes (The Lindner Research Center at The Christ Hospital, Cincinnati, OH, US) co-principal investigator of the DAPT Study, discusses the effectiveness of short-term DAPT in the prevention of stent thrombosis following stent implantation.
Questions:
1. How does the duration of DAPT affect clinical outcomes?
2. Why is there a debate about DAPT duration?
3. What is the clinical…
View more
Author(s):
Philippe Gabriel Steg
Added:
1 year ago
This broadcast series 'Where Do Potent P2Y12 Inhibitors Fit Into Current Practice?'will reappraise potent P2Y12 inhibitors, as evidence accumulates to support their broader use. At this juncture, there is still some uncertainty around patient selection, initiation and long-term management.
The fourth, and final, broadcast in this series, focused on Stroke Prevention.In this on-demand…
View more
Author(s):
Adnan Kastrati
Added:
3 years ago
Compared with conventional bare-metal stents (BMS), the introduction of drug-eluting stents (DES) has resulted in a substantial reduction in the incidence of in-stent restenosis.1 DES systems eluting either sirolimus2 or paclitaxel3 from a polymer stent coating have been shown in randomised trials to effectively inhibit the process of neointimal proliferation, resulting in restenosis reduction.
…
View more
Author(s):
Saad M Ezad
,
Girish Babu
,
Peter O’Kane
Added:
11 months ago
Author(s):
Andrea Pacchioni
,
Dimitris Nikas
,
Carlo Penzo
,
et al
Added:
3 years ago
Transcatheter aortic valve implantation (TAVI) and endovascular aortic repair (EVAR) are increasingly being used as therapeutic options for patients with severe aortic stenosis ineligible for surgery and with aortic aneurysm with suitable anatomical features. Despite encouraging results from randomised studies and registries regarding the pursuit of endovascular treatment in selected patients,…
View more
Felix Mahfoud
Research Area(s) / Expertise:
Job title: Associate Professor and Senior Physician
Author
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
5 years ago
Dr Nicolas van Mieghem and Dr Joost Daemen (Erasmus MC, Rotterdam, NL) discuss and analyse the late-breaking trials at AHA 2018.
View more
Novo Nordisk
Supplier
Author(s):
Nicolas M Van Mieghem
,
Joost Daemen
Added:
5 years ago
Whether you are attending or not, watch Dr Nicolas Van Mieghem and Dr Joost Daemen analyse what to expect from this year's late breaking trials at #ACC19 in the latest instalment of ‘View from the Thoraxcenter’. Topics covered include wearable technology, low-risk TAVI/R, mitraclip, anticoagulation, DAPT, coronary physiology, hypertension and heart failure.
Trials covered in this video:
00:33 -…
View more